Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - REMINDER: Zealand Pharma's Capital Markets Day on December 11, 2025
REMINDER: Zealand Pharma's Capital Markets Day on December 11, 2025
GlobeNewswire

Press release – No. 17 / 2025 REMINDER: Zealand Pharma's Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery…

thestar.com.my - RAGANANTHINI VETHASALAM - Health and Finance ministries finalise PPO Plus to secure local pharma supply
Health and Finance ministries finalise PPO Plus to secure local pharma supply
The Star Online

Nation KUALA LUMPUR: The Health and Finance Ministries are finalising the Off Take Plus Programme agreement to secure local pharmaceutical supply and boost domestic investment. Health Minister Datuk Seri Dr Dzulkefly Ahmad said this includes…

ibtimes.co.uk - Rohit David - Trump Tariff U-Turn: Zero-Tariff Pharma Deal Seals Win for UK Exports
Trump Tariff U-Turn: Zero-Tariff Pharma Deal Seals Win for UK Exports
International Business Times UK

In a dramatic reversal, Britain has secured a groundbreaking UK-US zero-tariff deal on pharmaceuticals, compelling US President Donald Trump to back down from his bold trade threats. The agreement, unveiled on 1 December 2025, underscores how…

thehindu.com - The Hindu Bureau - Sai Parenteral acquires stake in Australian pharma firm for ₹125 crore
Sai Parenteral acquires stake in Australian pharma firm for ₹125 crore
The Hindu

IPO-bound pharmaceutical formulations company Sai Parenteral's has acquired 74.6% stake in Adelaide-based Noumed Pharmaceuticals for ₹125 crore. With AUD 60 million in revenue, Noumed is a supplier of private label over-the-counter (OTC)…

law360.co.uk - Dylan Moroses - UK To Raise Pharma Spending For US Tariff Protection
UK To Raise Pharma Spending For US Tariff Protection
Law360

The United States and United Kingdom announced a deal Monday that includes a commitment to exclude U.K. pharmaceutical imports from any future U.S. tariff actions while the U.K. will pay higher... To view the full article, register now. Already a…

theguardian.com - Lisa O’Carroll - UK and US agree zero-tariff pharmaceuticals deal
UK and US agree zero-tariff pharmaceuticals deal
The Guardian

The UK government has sealed a deal with Donald Trump guaranteeing that zero tariffs will remain on the imports of UK pharmaceuticals into the US and commits Britain to higher spending on NHS drugs. The agreement, announced on Monday, secures…

marketbeat.com - XTX Topco Ltd Increases Stake in Ascendis Pharma A/S $ASND
XTX Topco Ltd Increases Stake in Ascendis Pharma A/S $ASND
MarketBeat

XTX Topco Ltd boosted its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 61.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,066…

thehindubusinessline.com - Pharma exports set for healthy growth as innovator drugs go off patents in five years: Pharmexcil Vice-Chairman
Pharma exports set for healthy growth as innovator drugs go off patents in five years: Pharmexcil Vice-Chairman
BusinessLine

Pharmaceutical exports are expected to continue on a healthy trajectory over the next few years with products worth over $250 billion poised to go off patents by 2030, said Pharmaceuticals Export Promotion Council ( Pharmexcil) Vice-Chairman Bhavin…

forbes.com - Sasirekha Subramanian - The Bigger Threat To Nvidia Is Not Google
The Bigger Threat To Nvidia Is Not Google
Forbes

Google logo on wall-mounted sign at office entrance, San Francisco, California, September 18, 2025. (Photo by Smith Collection/Gado/Getty Images) In the pharma industry, when a generic drug wins approval, it creates a structural market shift. Being…

wwd.com - Kathryn Hopkins - Barbara Lavernos on Beauty's Radical Transformation: Personalization, Sustainability, and Science and Technology's Convergence
Barbara Lavernos on Beauty's Radical Transformation: Personalization, Sustainability, and Science and Technology's Convergence
WWD

Barbara Lavernos may have been at L'Oréal for 34 years, but she has never seen such radical shifts in the beauty industry as there are currently. “The last years have been accelerating in terms of change like never before.

inquisitr.com - Tracey Ashlee - US and UK Seal Zero-Tariffs Pharmaceutical Deal Boosting Drug Spending
US and UK Seal Zero-Tariffs Pharmaceutical Deal Boosting Drug Spending
Inquisitr News

The United States and the United Kingdom have unveiled a landmark agreement that slashes tariffs to zero on British pharmaceuticals, medical ingredients, and medical technology exported to the US, per BBC. Under the accord, which forms part of the…

republicworld.com - Asian News International - Stock Market Today: Nifty50, BSE Sensex Open Under Pressure Amid Weak Rupee, FPI Outflows
Stock Market Today: Nifty50, BSE Sensex Open Under Pressure Amid Weak Rupee, FPI Outflows
Republic World

The domestic share market opened on a weak note on Tuesday as both the benchmark indices slipped into negative territory, weighed down by a falling rupee and continued foreign portfolio investor (FPI) outflows. The Nifty 50 index opened at…

standard.co.uk - Anna Wise - UK and US preparing to strike zero tariffs deal on pharmaceuticals
UK and US preparing to strike zero tariffs deal on pharmaceuticals
Evening Standard

Sign up for our email featuring expert insight and funding opportunities for entrepreneurs and SMEs I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. The UK Government is preparing to strike…

independent.co.uk - Helen Corbett - Zero-tariff deal with US to cost NHS £1 billion, No 10 says
Zero-tariff deal with US to cost NHS £1 billion, No 10 says
The Independent

A deal that gives the US zero tariffs on its imports of UK pharmaceuticals in return for the NHS raising spending on medicines will cost around £1 billion, Downing Street has said. The agreement sees the UK's threshold for what it can pay for…

forbes.com - Bryan Lapidus - CFOs: Deliver Value Through Agile Processes
CFOs: Deliver Value Through Agile Processes
Forbes

Bryan Lapidus, FPAC, develops corporate finance practitioners at the Association for Financial Professionals. Traditional finance processes were designed for stability: annual budgets, rigid reporting cycles and exhaustive measurement frameworks.

Receive a Daily briefing on Pharma Industry News

Get Started